iC9-GD2-CAR-VZV-CTLs
/ Baylor College of Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 23, 2021
VEGAS: iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
(clinicaltrials.gov)
- P1; N=26; Active, not recruiting; Sponsor: Baylor College of Medicine; Trial completion date: Apr 2036 ➔ Oct 2034
Clinical • Trial completion date • Neuroblastoma • Oncology • Osteosarcoma • Sarcoma • Solid Tumor
1 to 1
Of
1
Go to page
1